Aerobic glycolysis in osteoblasts

Current Osteoporosis Reports

Volumn 12, Issue 4, 2014, Pages 433-438

  Esen, Emel ^a   Long, Fanxin ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aerobic glycolysis; Bone formation; Energy; Glucosemetabolism; Osteoblast

Indexed keywords

GLUCOSE TRANSPORTER; INSULIN; LACTIC ACID; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; SOMATOMEDIN B; SOMATOMEDIN C; WNT PROTEIN; GLUCOSE;

AEROBIC GLYCOLYSIS; AEROBIC METABOLISM; ARTICLE; BIOSYNTHESIS; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL METABOLISM; DRUG MECHANISM; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; INSULIN DEFICIENCY; METABOLIC REGULATION; NONHUMAN; OSSIFICATION; OSTEOBLAST; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL MODEL; CYTOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; GLUCOSE; HUMANS; MODELS, ANIMAL; OSTEOBLASTS; OSTEOGENESIS; PARATHYROID HORMONE;

EID: 84917736109     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-014-0235-y     Document Type: Article

References (62)

1. Long F.Building strong bones:molecular regulation of the osteoblast lineage.Nat Rev Mol Cell Biol.2012;13(1):27-38.
2. O'Brien CA, Nakashima T, Takayanagi H.Osteocyte control of osteoclastogenesis.Bone.2013;54(2):258-63.
3. Teitelbaum SL, Ross FP.Genetic regulation of osteoclast development and function.Nat Rev Genet.2003;4(8):638-49.
4. Feng JQ, Clinkenbeard EL, Yuan B, White KE, Drezner MK.Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia.Bone.2013;54(2):213-21.
5. Clemens TL, Karsenty G.The osteoblast:an insulin target cell controlling glucose homeostasis.J Bone Miner Res.2011;26(4):677-80.
6. Bell GI, Burant CF, Takeda J, Gould GW.Structure and function of mammalian facilitative sugar transporters.J Biol Chem.1993;268(26):19161-4.
7. Mueckler M.Facilitative glucose transporters.Eur J Biochem.1994;219(3):713-25.
8. Bouche C, Serdy S, Kahn CR, Goldfine AB.The cellular fate of glucose and its relevance in type 2 diabetes.Endocr Rev.2004;25(5):807-30.
9. Kopperschlager G, Kirchberger J.Methods for the separation of lactate dehydrogenases and clinical significance of the enzyme.J Chromatogr B Biomed Appl.1996;684(1-2):25-49.
10. Perl A, Hanczko R, Telarico T, Oaks Z, Landas S.Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase.TrendsMolMed.2011;17(7):395-403.
11. Wamelink MM, Struys EA, Jakobs C.The biochemistry, metabolism and inherited defects of the pentose phosphate pathway:a review.J Inherit Metab Dis.2008;31(6):703-17.
12. Teo CF, Wollaston-Hayden EE, Wells L.Hexosamine flux, the OGlcNAc modification, and the development of insulin resistance in adipocytes.Mol Cell Endocrinol.2010;318(1-2):44-53.
13. Thomas DM, Rogers SD, Ng KW, Best JD.Dexamethasone modulates insulin receptor expression and subcellular distribution of the glucose transporter GLUT 1 in UMR 106-01, a clonal osteogenic sarcoma cell line.J Mol Endocrinol.1996;17(1):7-17.
14. Thomas DM, Maher F, Rogers SD, Best JD.Expression and regulation by insulin of GLUT 3 in UMR 106-01, a clonal rat osteosarcoma cell line.Biochem Biophys Res Commun.1996;218(3):789- 93.
15. Rolland F, Winderickx J, Thevelein JM.Glucose-sensing mechanisms in eukaryotic cells.Trends Biochem Sci.2001;26(5):310-7.
16. Borle AB, Nichols N, Nichols Jr G.Metabolic studies of bone in vitro.I.Normal bone.J Biol Chem.1960;235:1206-10.
17. Cohn DV, Forscher BK.Aerobic metabolism of glucose by bone.J Biol Chem.1962;237:615-8.
18. Flanagan B, Nichols Jr G.Metabolic studies of bone in vitro.V.glucose metabolism and collagen biosynthesis.J Biol Chem.1964;239:1261-5.
19. Peck WA, Birge Jr SJ, Fedak SA.Bone cells:biochemical and biological studies after enzymatic isolation.Science.1964;146(3650):1476-7.
20. Guntur AR, Le PT, Farber CR, Rosen CJ.Bioenergetics during calvarial osteoblast differentiation reflect strain differences in bone mass.Endocrinology.2014;155(5):1589-95.This study shows that both glycolysis and oxygen comsumption increase during calvarial osteoblast differentiation but mature osteoblasts are more dependent on glycolysis.In addition, oxygen consumption rates in calvarial osteoblast cultures positively correlate with bone formation rate in vivo across different inbred mouse strains.
21. Regan JN, Lim J, Shi Y, et al.Up-regulation of glycolytic metabolism is required for HIF1alpha-driven bone formation.Proc Natl Acad Sci U S A.2014;111(23):8673-8.This work provides evidence that increased glycolysis contributes to more robust cancellous bone formation in the mouse.
22. Warburg O.On the origin of cancer cells.Science.1956;123(3191):309-14.
23. Gatenby RA, Gillies RJ.Why do cancers have high aerobic glycolysis? Nat Rev Cancer.2004;4(11):891-9.
24. Vander Heiden MG, Cantley LC, Thompson CB.Understanding theWarburg effect:the metabolic requirements of cell proliferation.Science.2009;324(5930):1029-33.
25. Dixon TF, Perkins HR.Citric acid and bone metabolism.Biochem J.1952;52(2):260-5.
26. Costello LC, Franklin RB, Reynolds MA, Chellaiah M.The important role of osteoblasts and citrate production in bone formation:"Osteoblast Citration" as a new concept for an old relationship.Open Bone J.2012;4.
27. Hu YY, Rawal A, Schmidt-Rohr K.Strongly bound citrate stabilizes the apatite nanocrystals in bone.Proc Natl Acad Sci U S A.2010;107(52):22425-9.
28. Kenny AD, Draskoczy PR, Goldhaber P.Citric acid production by resorbing bone in tissue culture.Am J Physiol.1959;197:502-4.
29. Taylor TG.The nature of bone citrate.Biochim Biophys Acta.1960;39:148-9.
30. Costello LC, Liu Y, Franklin RB, Kennedy MC.Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells.J Biol Chem.1997;272(46):28875-81.
31. Alhava EM, Olkkonen H, Puittinen J, Nokso-Koivisto VM.Zinc content of human cancellous bone.Acta Orthop Scand.1977;48(1):1-4.
32. Inoue K, Matsuda K, Itoh M, et al.Osteopenia and male-specific sudden cardiac death in mice lacking a zinc transporter gene, Znt5.Hum Mol Genet.2002;11(15):1775-84.
33. Tang Z, Sahu SN, Khadeer MA, Bai G, Franklin RB, Gupta A.Overexpression of the ZIP1 zinc transporter induces an osteogenic phenotype in mesenchymal stem cells.Bone.2006;38(2):181-98.
34. Borle AB, Nichols N, Nichols Jr G.Metabolic studies of bone in vitro.II.The metabolic patterns of accretion and resorption.J Biol Chem.1960;235:1211-4.
35. Neuman WF, Neuman MW, Brommage R.Aerobic glycolysis in bone:lactate production and gradients in calvaria.Am J Physiol.1978;234(1):C41-50.
36. Rodan GA, Rodan SB, Marks Jr SC.Parathyroid hormone stimulation of adenylate cyclase activity and lactic acid accumulation in calvaria of osteopetrotic (ia) rats.Endocrinology.1978;102(5):1501-5.
37. Zoidis E, Ghirlanda-Keller C, Schmid C.Stimulation of glucose transport in osteoblastic cells by parathyroid hormone and insulinlike growth factor I.Mol Cell Biochem.2011;348(1-2):33-42.
38. Maupin KA, Droscha CJ, Williams BO.A comprehensive overview of skeletal phenotypes associated with alterations in Wnt/b-catenin signaling in humans and mice.Bone Res.2013;1(1):27-71.
39. Esen E, Chen J, Karner CM, Okunade AL, Patterson BW, Long F.WNT-LRP5 signaling induces Warburg effect through mTORC2 activation during osteoblast differentiation.Cell Metab.2013;17(5):745-55.This work provides evidence that Wnt signaling directly stimulates aerobic glycolysis during osteoblast differentiation.
40. Kemink SA, Hermus AR, Swinkels LM, Lutterman JA, Smals AG.Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.J Endocrinol Investig.2000;23(5):295-303.
41. Nicodemus KK, Folsom AR.Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women.Diabetes Care.2001;24(7):1192-7.
42. Loder RT.The influence of diabetes mellitus on the healing of closed fractures.Clin Orthop Relat Res.1988;232:210-6.
43. Levin ME, Boisseau VC, Avioli LV.Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes.N Engl J Med.1976;294(5):241-5.
44. Verhaeghe J, van Herck E, Visser WJ, et al.Bone and mineral metabolism in BB rats with long-term diabetes.Decreased bone turnover and osteoporosis.Diabetes.1990;39(4):477-82.
45. Lu H, Kraut D, Gerstenfeld LC, Graves DT.Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation.Endocrinology.2003;144(1):346-52.
46. Gandhi A, Beam HA, O'Connor JP, Parsons JR, Lin SS.The effects of local insulin delivery on diabetic fracture healing.Bone.2005;37(4):482-90.
47. FerronM,Wei J, Yoshizawa T, et al.Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism.Cell.2010;142(2):296-308.
48. Fulzele K, Riddle RC, DiGirolamo DJ, et al.Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition.Cell.2010;142(2):309-19.
49. Thrailkill K, Bunn RC, Lumpkin Jr C, et al.Loss of insulin receptor in osteoprogenitor cells impairs structural strength of bone.J Diabetes Res.2014;2014:703589.
50. KawaiM, Rosen CJ.The insulin-like growth factor systemin bone:basic and clinical implications.Endocrinol Metab Clin N Am.2012;41(2):323-33.vi.
51. Nakae J, Kido Y, Accili D.Distinct and overlapping functions of insulin and IGF-I receptors.Endocr Rev.2001;22(6):818-35.
52. Bikle D, Majumdar S, Laib A, et al.The skeletal structure of insulin-like growth factor I-deficient mice.J Bone Miner Res.2001;16(12):2320-9.
53. Zhao G, Monier-Faugere MC, Langub MC, et al.Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice:increased trabecular bone volume without increased osteoblast proliferation.Endocrinology.2000;141(7):2674-82.
54. Govoni KE, Wergedal JE, Florin L, Angel P, Baylink DJ, Mohan S.Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion.Endocrinology.2007;148(12):5706-15.
55. Xian L,Wu X, Pang L, et al.Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells.Nat Med.2012;18(7):1095-101.
56. Zhang M, Xuan S, Bouxsein ML, et al.Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization.J Biol Chem.2002;277(46):44005-12.
57. Brabant G, von zur Muhlen A, Wuster C, et al.Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system:results from a multicenter study.Horm Res.2003;60(2):53-60.
58. Seck T, Scheppach B, Scharla S, et al.Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bonematrix frompre- and postmenopausal women:relationship to age, menopause, bone turnover, bone volume, and circulating IGFs.J Clin Endocrinol Metab.1998;83(7):2331-7.
59. Cao JJ, Kurimoto P, Boudignon B, Rosen C, Lima F, Halloran BP.Aging impairs IGF-I receptor activation and induces skeletal resistance to IGF-I.J Bone Miner Res.2007;22(8):1271-9.
60. Bikle DD, Sakata T, Leary C, et al.Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone.J Bone Miner Res.2002;17(9):1570-8.
61. WangY, Nishida S, Boudignon BM, et al.IGF-I receptor is required for the anabolic actions of parathyroid hormone on bone.J Bone Miner Res.2007;22(9):1329-37.
62. Miyakoshi N, Kasukawa Y, Linkhart TA, Baylink DJ, Mohan S.Evidence that anabolic effects of PTH on bone require IGF-I in growing mice.Endocrinology.2001;142(10):4349-56.